Literature DB >> 8829878

[Serodiagnosis of toxoplasmosis: a comparative multicenter study of a standard scale through various actual tests and expression of the results in international units. Groupe de travail toxoplasmose du Contrôle national de qualité en parasotologie. Syndicat des fabricants de réactifs de laboratoire. Groupe de travail standardisation des tests sérologiques du Réseau européen de lutte contre la toxoplasmose congénitale].

J C Petithory1, P Ambroise-Thomas, J De Loye, H Pelloux, A Goullier-Fleuret, M Milgram, C Buffard, J P Garin.   

Abstract

Reported are the results of a multicentre study involving 40 laboratories that was carried out in France to assess all the currently available methods used for the serodiagnosis of toxoplasmosis. For this purpose 10 batches of control sera were prepared with titres in the range 0-260 IU per ml. These sera were tested in nine laboratories using immunofluorescence methods; in three laboratories using dye tests; in forty laboratories using enzyme-linked immunosorbent assay; in four laboratories using direct agglutination and haemagglutination; in seven laboratories using the high-sensitivity IgG agglutination test; and in three laboratories using the latex agglutination test. In this way, 70 series of titrations were carried out using seven procedures and the results were compared with those obtained using the WHO reference serum in 15 cases, with the French national E6 serum in 16 other cases, and in 39 cases using 15 reference sera supplied by the reagent manufacturers. Rigorous comparison of the tests was not possible in all cases because one aim of the study was to ensure that the tests were carried out under the usual working conditions that prevailed in the participating laboratories. The results obtained indicate that the serological tests currently available for toxoplasmosis are acceptable for its serodiagnosis. Presentation of the titres in IU has advantages; however, caution is required since the definition of IU varies according to the test and reagents used. It is therefore essential that the conditions and limits for a positive reaction be carefully defined in each case, especially for commercially available kits.

Entities:  

Mesh:

Year:  1996        PMID: 8829878      PMCID: PMC2486922     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  7 in total

1.  [THE SEROLOGICAL DIAGNOSIS OF TOXOPLASMOSIS BY THE FLUORESCENT ANTIBODY METHOD (INDIRECT TECHNIC)].

Authors:  J P GARIN; P AMBROISE-THOMAS
Journal:  Presse Med       Date:  1963-12-07       Impact factor: 1.228

2.  [Comparative study of antitoxoplasmic IgG isotypes titrated by high sensitivity direct agglutination and indirect immunofluorescence: consequence of the choice of methods on the expression of results in international units].

Authors:  D Puygauthier-Toubas; D Jolly; O Bajolet; T Moreaux; C Marx-Chemla; A Bonhomme; F Blanchard; J M Pinon
Journal:  Ann Biol Clin (Paris)       Date:  1990       Impact factor: 0.459

3.  [Quantitiative immunofluorescent antibody technic and serological diagnosis of toxoplasmosis: introduction of international units in the expression of positive results].

Authors:  G Niel; G Desmonts; M Gentilini
Journal:  Pathol Biol (Paris)       Date:  1973-02

4.  Evaluation of commercial serodiagnostic kits for toxoplasmosis.

Authors:  M Wilson; D A Ware; K W Walls
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

Review 5.  A role for IFN-gamma and NK cells in immune responses to T cell-regulated antigens types 1 and 2.

Authors:  J J Mond; M Brunswick
Journal:  Immunol Rev       Date:  1987-10       Impact factor: 12.988

6.  Evaluation of the enzyme-linked immunosorbent assay (ELISA) and other serological tests for the diagnosis of toxoplasmosis.

Authors:  Y Carlier; D Bout; J P Dessaint; A Capron; F Van Knapen; E J Ruitenberg; R Bergquist; G Huldt
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

7.  [Multicenter study of toxoplasma serology using various commercial ELISA reagents. Work Group Toxoplasmosis of the National Agency for Quality Control in Parasitology].

Authors:  F Derouin; Y J Garin; C Buffard; F Berthelot; J C Petithory
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

  7 in total
  8 in total

1.  Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot.

Authors:  Arnaud Maudry; Gautier Chene; Rémi Chatelain; Hugues Patural; Bahrie Bellete; Bernard Tisseur; Jamal Hafid; Hélène Raberin; Sophie Beretta; Roger Tran Manh Sung; Georges Belot; Pierre Flori
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

2.  Discrepancies between a new highly sensitive Toxoplasma gondii ELISA assay and other reagents: interest of Toxo IgG Western blot.

Authors:  F Leslé; F Touafek; A Fekkar; D Mazier; L Paris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

3.  Detection of anti-Toxoplasma immunoglobulin M in pregnant women.

Authors:  H Pelloux; H Fricker-Hidalgo; A Goullier-Fleuret; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

4.  Help in the Choice of Automated or Semiautomated Immunoassays for Serological Diagnosis of Toxoplasmosis: Evaluation of Nine Immunoassays by the French National Reference Center for Toxoplasmosis.

Authors:  O Villard; B Cimon; C L'Ollivier; H Fricker-Hidalgo; N Godineau; S Houze; L Paris; H Pelloux; I Villena; E Candolfi
Journal:  J Clin Microbiol       Date:  2016-10-12       Impact factor: 5.948

Review 5.  Toxoplasma gondii: from animals to humans.

Authors:  A M Tenter; A R Heckeroth; L M Weiss
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

6.  The impact of lowering the cut-off value on the sensitivity of the Platelia Elisa IgG (Bio-Rad) test for toxoplasmosis diagnosis.

Authors:  Oussama Mouri; Eric Kendjo; Feriel Touafek; Arnaud Fekkar; Ousmane Konte; Sebastien Imbert; Régis Courtin; Dominique Mazier; Luc Paris
Journal:  Parasite       Date:  2015-07-17       Impact factor: 3.000

7.  A new IgG immunoblot kit for diagnosis of toxoplasmosis in pregnant women.

Authors:  Imen Khammari; Fatma Saghrouni; Sami Lakhal; Aida Bouratbine; Moncef Ben Said; Jalel Boukadida
Journal:  Korean J Parasitol       Date:  2014-10-22       Impact factor: 1.341

8.  Anti-Toxoplasma IgG assays: What performances for what purpose? A systematic review.

Authors:  Florence Robert-Gangneux; Hélène Guegan
Journal:  Parasite       Date:  2021-04-26       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.